Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

GlucoTrack Q2 EPS $(9.62) Up From $(984.00) YoY

Author: Benzinga Newsdesk | August 14, 2025 04:47pm
GlucoTrack (NASDAQ:GCTK) reported quarterly losses of $(9.62) per share. This is a 99.02 percent increase over losses of $(984.00) per share from the same period last year.

Posted In: GCTK

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist